4.5 Article

Epidemiology of Escherichia coli bacteraemia in England: results of an enhanced sentinel surveillance programme

期刊

JOURNAL OF HOSPITAL INFECTION
卷 95, 期 4, 页码 365-375

出版社

W B SAUNDERS CO LTD
DOI: 10.1016/j.jhin.2016.12.008

关键词

Urinary tract infection; Risk factors; Healthcare-associated; Community

资金

  1. Public Health England

向作者/读者索取更多资源

Background: Escherichia coli causes more than one-third of the bacteraemia cases in England each year, and the incidence of these infections is increasing. Aim: To determine the underlying risk factors associated with E. coli bacteraemia. Methods: A three-month enhanced sentinel surveillance study involving 35 National Health Service hospitals was undertaken in the winter of 2012/13 to collect risk factor information and further details on the underlying source of infection to augment data already collected by the English national surveillance programme. Antimicrobial susceptibility results for E. coli isolated from blood and urine were also collected. Findings: A total of 1731 cases of E. coli bacteraemia were included. The urogenital tract was the most frequently reported source of infection (51.2% of cases) with previous treatment for a urinary tract infection being the largest independent effect associated with this infection source. Half of all patients had previous healthcare exposure in the month prior to the bacteraemia with antimicrobial therapy and urinary catheterization being reported in one-third and one-fifth of these patients, respectively. Previous healthcare exposure was associated with a higher proportion of antibiotic non-susceptibility in the blood culture isolates (P = 0.001). Conclusion: Analysis of risk factors suggests the potential benefit of community-and hospital-related interventions, especially the better use of urinary catheters and improved antibiotic management of urinary tract infections. As part of the latter strategy, antibiotic resistance profiles need to be closely monitored to ensure that treatment guidelines are up to date to limit inappropriate empiric therapy. (C) 2016 Published by Elsevier Ltd on behalf of The Healthcare Infection Society.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Immunology

Changing Patterns of Bloodstream Infections in the Community and Acute Care Across 2 Coronavirus Disease 2019 Epidemic Waves: A Retrospective Analysis Using Data Linkage

Nina J. Zhu, Timothy M. Rawson, Siddharth Mookerjee, James R. Price, Frances Davies, Jonathan Otter, Paul Aylin, Russell Hope, Mark Gilchrist, Yeeshika Shersing, Alison Holmes

Summary: The COVID-19 pandemic has affected the patterns of community- and hospital-acquired bloodstream infections in COVID-19 and non-COVID-19 patients. There was a high incidence of hospital-acquired bacteremia during the COVID-19 waves, especially in SARS-CoV-2-negative elective patients.

CLINICAL INFECTIOUS DISEASES (2022)

Article Public, Environmental & Occupational Health

Quantifying the contribution of pathways of nosocomial acquisition of COVID-19 in English hospitals

Stephanie Evans, James Stimson, Diane Pople, Alex Bhattacharya, Russell Hope, Peter J. White, Julie Robotham

Summary: Despite evidence of nosocomial transmission of SARS-CoV-2 in hospitals, the contributions of different transmission pathways are poorly quantified. This study analyzed national hospital records and found that indirect transmission between patients, such as through healthcare workers or contaminated objects, was the most likely route of nosocomial transmission. The risk of transmission to patients from healthcare workers is low but significant when the number of infected patients is low. The risk of healthcare workers acquiring SARS-CoV-2 in the hospital is equal to that in the community.

INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2022)

Article Medicine, General & Internal

Duration of Protection against Mild and Severe Disease by Covid-19 Vaccines

Nick Andrews, Elise Tessier, Julia Stowe, Charlotte Gower, Freja Kirsebom, Ruth Simmons, Eileen Gallagher, Simon Thelwall, Natalie Groves, Gavin Dabrera, Richard Myers, Colin N. J. Campbell, Gayatri Amirthalingam, Matt Edmunds, Maria Zambon, Kevin Brown, Susan Hopkins, Meera Chand, Shamez N. Ladhani, Mary Ramsay, Jamie Lopez Bernal

Summary: A study conducted in England showed that vaccines against SARS-CoV-2 provide high protection against hospitalization and death from Covid-19 at 20 weeks or more after vaccination. However, the effectiveness of the vaccines decreases over time, especially in individuals aged 65 and older and those with underlying risk factors.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Infectious Diseases

T-cell and antibody responses to first BNT162b2 vaccine dose in previously infected and SARS-CoV-2-naive UK health-care workers: a multicentre prospective cohort study

Adrienn Angyal, Stephanie Longet, Shona C. Moore, Rebecca P. Payne, Adam Harding, Tom Tipton, Patpong Rongkard, Mohammad Ali, Luisa M. Hering, Naomi Meardon, James Austin, Rebecca Brown, Donal Skelly, Natalie Gillson, Sue L. Dobson, Andrew Cross, Gurjinder Sandhar, Jonathan A. Kilby, Jessica K. Tyerman, Alexander R. Nicols, Jarmila S. Spegarova, Hema Mehta, Hailey Hornsby, Rachel Whitham, Christopher P. Conlon, Katie Jeffery, Philip Goulder, John Frater, Christina Dold, Matthew Pace, Ane Ogbe, Helen Brown, M. Azim Ansari, Emily Adland, Anthony Brown, Meera Chand, Adrian Shields, Philippa C. Matthews, Susan Hopkins, Victoria Hall, William James, Sarah L. Rowland-Jones, Paul Klenerman, Susanna Dunachie, Alex Richter, Christopher J. A. Duncan, Eleanor Barnes, Miles Carroll, Lance Turtle, Thushan de Silva

Summary: This study compares immune responses to the BNT162b2 mRNA vaccine in healthcare workers with and without previous SARS-CoV-2 infection. The results show that previously infected individuals have stronger spike-specific T-cell and antibody responses after receiving a single dose of the vaccine compared to SARS-CoV-2-naive individuals. This suggests that a single dose of the BNT162b2 vaccine is likely to provide better protection against SARS-CoV-2 infection in individuals with previous infection.

LANCET MICROBE (2022)

Article Dermatology

Long-term oral antibiotic use in people with acne vulgaris in UK primary care: a drug utilization study

Ketaki Bhate, Kathryn E. Mansfield, Sarah-Jo Sinnott, David J. Margolis, Elizabeth Adesanya, Nick Francis, Clemence Leyrat, Susan Hopkins, Richard Stabler, Laura Shallcross, Sinead M. Langan, Rohini Mathur

Summary: This study investigated the use of oral antibiotics for moderate-to-severe acne vulgaris using primary care data. It was found that 44.5% of individuals received long-term oral antibiotic treatment, with a median of four continuous courses per person. Further research is needed to understand the consequences of using antibiotics for shorter periods.

BRITISH JOURNAL OF DERMATOLOGY (2023)

Article Infectious Diseases

Increase in invasive group A streptococcal infection notifications, England, 2022

Rebecca Guy, Katherine L. Henderson, Juliana Coelho, Helen Hughes, Emily L. Mason, Sarah M. Gerver, Alicia Demirjian, Conall Watson, Ashley Sharp, Colin S. Brown, Theresa Lamagni

Summary: There has been an increase in invasive group A streptococcal (iGAS) infection and associated deaths, especially in children, exceeding seasonally expected levels in England (772 notifications reported in weeks 37 to 48 in 2022). Diagnoses of iGAS infection from lower respiratory tract specimens in children under 15 years increased to 28% in November 2022. Medical practitioners have been alerted to the exceptional rise in incidence, including unusual numbers of children presenting with pulmonary empyema.

EUROSURVEILLANCE (2023)

Letter Pediatrics

Paediatric group A streptococcal disease in England from October to December, 2022

Shamez N. Ladhani, Rebecca Guy, Sunil S. Bhopal, Colin S. Brown, Theresa Lamagni, Ashley Sharp

LANCET CHILD & ADOLESCENT HEALTH (2023)

Article Infectious Diseases

Comparison of the risk of hospitalisation among BA.1 and BA.2 COVID-19 cases treated with sotrovimab in the community in England

Katie Harman, Sophie Grace Nash, Harriet H. Webster, Natalie Groves, Jo Hardstaff, Jessica Bridgen, Paula B. Blomquist, Russell Hope, Efejiro Ashano, Richard Myers, Sakib Rokadiya, Susan Hopkins, Colin S. Brown, Meera Chand, Gavin Dabrera, Simon Thelwall

Summary: There are concerns about the reduced efficacy of sotrovimab in reducing hospitalisation risk for the BA.2 sub-lineage of the Omicron variant. A retrospective study was conducted to compare the risk of hospitalisation between BA.2 and BA.1 cases treated with sotrovimab. The results suggest that the risk of hospital admission was similar for both sub-lineages.

INFLUENZA AND OTHER RESPIRATORY VIRUSES (2023)

Article Microbiology

Is Panton-Valentine leucocidin (PVL) toxin associated with poor clinical outcomes in patients with community- acquired Staphylococcus aureus bacteraemia?

Emma McGuire, Claire Neill, Simon M. Collin, Hannah Higgins, Rebecca Guy, Mark Ganner, Juliana Coelho, Bruno Pichon, Russell Hope, Colin S. Brown

Summary: PVL toxin detection was not associated with worse outcomes in patients with community-acquired S. aureus bacteremia.

JOURNAL OF MEDICAL MICROBIOLOGY (2023)

Editorial Material Pediatrics

Paediatric group A streptococcal disease in England: a primary care perspective

Shamez N. Ladhani, Rebecca Guy, Helen E. Hughes, Alex J. Elliot, Sunil S. Bhopal, Colin Brown, Theresa Lamagni

LANCET CHILD & ADOLESCENT HEALTH (2023)

Article Public, Environmental & Occupational Health

Determining the impact of professional body recommendations on the screening of acquired carbapenemase-producing Enterobacterales in England

Kirsty F. Bennet, Rebecca L. Guy, Sarah M. Gerver, Katie L. Hopkins, Richard Puleston, Colin S. Brown, Katherine L. Henderson

Summary: Hospitals in England have screening policies for carbapenemase-producing Enterobacterales (CPE), but the RCPath recommendations had minimal impact on reducing CPE screening. The reduction in screening was primarily due to a decrease in patient admissions related to the COVID-19 pandemic.

INFECTION PREVENTION IN PRACTICE (2023)

Letter Infectious Diseases

Risk of severe outcomes among SARS-CoV-2 Omicron BA.4 and BA.5 cases compared to BA.2 cases in England

Nurin Abdul Aziz, Sophie Grace Nash, Asad Zaidi, Tommy Nyberg, Natalie Groves, Russell Hope, Jamie Lopez Bernal, Gavin Dabrera, Simon Thelwall

JOURNAL OF INFECTION (2023)

Article Infectious Diseases

Nitrofurantoin resistance as an indicator for multidrug resistance: an assessment of Escherichia coli urinary tract specimens in England, 2015-19

Rebecca L. Guy, Jamie Rudman, Hannah Higgins, Emma Carter, Katherine L. Henderson, Alicia Demirjian, Sarah M. Gerver

Summary: This study in England reveals that MDR and XDR phenotypes occur more frequently in nitrofurantoin-resistant Escherichia coli urinary isolates compared to nitrofurantoin-susceptible isolates.

JAC-ANTIMICROBIAL RESISTANCE (2023)

Article Infectious Diseases

Invasive group A streptococcal disease in pregnant women and young children: a systematic review and meta-analysis

Emma Sherwood, Stefania Vergnano, Isona Kakuchi, Michael G. Bruce, Suman Chaurasia, Samara David, Angela Dramowski, Scarlett Georges, Rebecca Guy, Theresa Lamagni, Daniel Levy-Bruhl, Outi Lyytikainen, Monika Naus, Jennifer Onukwube Okaro, Oddvar Oppegaard, Didrik F. Vestrheim, Tammy Zulz, Andrew C. Steer, Chris A. Van Beneden, Anna C. Seale

Summary: The study revealed a significant burden of invasive GAS in young children, with insufficient data on neonates and children in low- and middle-income countries, as well as a complete lack of data on pregnant women. Incidence of invasive GAS is likely underestimated, especially in low- and middle-income countries, due to limited GAS surveillance. Improving available data is crucial for the development of prevention and management strategies for invasive GAS.

LANCET INFECTIOUS DISEASES (2022)

暂无数据